NEUE KOMBINATIONSPRAEPARATE ZUR BEHANDLUNG DES MORBUS PARKINSON

The use of NMDA receptor antagonists for the symptomatic treatment of Parkinson's disease and combination products which have a synergistic action and contain NMDA receptor antagonists are described.

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	LOESCHMANN, PETER-ANDREAS, WACHTEL, HELMUT., 1000 BERLIN, DE
Format:	Patent
Sprache:	ger
Schlagworte:	HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

Beschreibung
Zusammenfassung:	The use of NMDA receptor antagonists for the symptomatic treatment of Parkinson's disease and combination products which have a synergistic action and contain NMDA receptor antagonists are described.